药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Olodaterol
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Olodaterol.
Benzonatate
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Chlorcyclizine.
Benzonatate
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Geranylgeranyl diphosphate.
Benzonatate
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Farnesyl diphosphate.
Benzonatate
Degarelix
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Degarelix.
Benzonatate
Mepyramine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mepyramine.
Benzonatate
Cariporide
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Cariporide.
Benzonatate
Amisulpride
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Amisulpride.
Benzonatate
Vernakalant
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Vernakalant.
Benzonatate
Tandutinib
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tandutinib.
Benzonatate
Methsuximide
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Methsuximide.
Benzonatate
Ezogabine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ezogabine.
Benzonatate
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Farnesyl thiopyrophosphate.
Benzonatate
Thiothixene
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Thiothixene.
Benzonatate
Pheniramine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Pheniramine.
Benzonatate
Ajmaline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ajmaline.
Benzonatate
Arformoterol
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Arformoterol.
Benzonatate
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Sunitinib.
Benzonatate
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Sunitinib.
Benzonatate
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Sunitinib.